HealthCare Global Enterprises Limited (HCG.NS)
INR 532.3
(-1.64%)
INR 532.3
(-1.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.84 Billion | 2.51 Billion | 2.2 Billion | 1.2 Billion | 1.3 Billion | 985.04 Million |
| Net Income | 677.2 Million | 448.7 Million | 877.72 Million | -2.28 Billion | -1.19 Billion | -333.75 Million |
| Depreciation & Amortization | 1.74 Billion | 1.63 Billion | 1.58 Billion | 1.59 Billion | 1.48 Billion | 850.85 Million |
| Deferred income taxes | - | -57.4 Million | -65.88 Million | 460.16 Million | -93.18 Million | -229.54 Million |
| Stock-based compensation | 78.5 Million | 65.1 Million | 31.03 Million | 19.12 Million | 28.31 Million | 30.56 Million |
| Change in working capital | -271.8 Million | -458.6 Million | -105.2 Million | -507.14 Million | -226.49 Million | 21.05 Million |
| Other non-cash items | 854.9 Million | 883.3 Million | -119.27 Million | 1.92 Billion | 1.3 Billion | 645.87 Million |
| Investing Cash Flow | -2.25 Billion | -1.33 Billion | 1.24 Billion | -1.71 Billion | -1.01 Billion | -2.38 Billion |
| Investments in PPE | -1.85 Billion | -1.33 Billion | -712.32 Million | -354.24 Million | -1.07 Billion | -1.88 Billion |
| Acquisitions | -450 Million | -20 Million | 379.9 Million | -52.48 Million | 36.43 Million | -379.57 Million |
| Investment purchases | -265.7 Million | -2 Million | -2.5 Million | -2.88 Billion | -14.21 Million | -159.75 Million |
| Sales/Maturities of investments | 900 Thousand | 501.92 Million | 147.37 Million | 1.51 Billion | 35.01 Million | 184.91 Million |
| Other Investing Activities | -50.5 Million | -477.82 Million | 1.43 Billion | 63.54 Million | 7.04 Million | -139.75 Million |
| Financing Cash Flow | -640.2 Million | -1.4 Billion | -1.54 Billion | 1.12 Billion | -584.25 Million | 835.11 Million |
| Debt repayment | -1.38 Billion | -637.6 Million | -3.45 Billion | -2.63 Billion | -362.25 Million | -2.53 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 19.5 Million | 8.9 Million | 1.32 Billion | 5.19 Billion | 203.18 Million | 930 Thousand |
| Other Financing Activities | -422 Million | -772 Million | 585.11 Million | -1.44 Billion | -425.18 Million | 3.36 Billion |
| Accounts receivables | -278.2 Million | -785.48 Million | -404.4 Million | -78.48 Million | -325.83 Million | -327.57 Million |
| Accounts payables | 99.5 Million | 563.47 Million | 442.92 Million | -528.9 Million | 181.88 Million | 461.72 Million |
| Inventory | -39.5 Million | -83.1 Million | -60.75 Million | 21.5 Million | 35.14 Million | -27.46 Million |
| Other working capital | -53.6 Million | -153.49 Million | -82.97 Million | 78.74 Million | -117.68 Million | -85.64 Million |
| Cash at beginning of period | 1.71 Billion | 1.92 Billion | 28.65 Million | -587.92 Million | -291.22 Million | 270.61 Million |
| Cash at end of period | 1.66 Billion | 1.71 Billion | 1.92 Billion | 28.65 Million | -587.92 Million | -291.22 Million |
| Capital Expenditure | -1.85 Billion | -1.33 Billion | -712.32 Million | -354.24 Million | -1.07 Billion | -1.88 Billion |
| Effect of forex changes on cash | - | 20 Thousand | - | - | 10 Thousand | - |
| Net cash flow / Change in cash | -51.7 Million | -215.1 Million | 1.89 Billion | 616.57 Million | -296.7 Million | -561.83 Million |
| Free Cash Flow | 989 Million | 1.18 Billion | 1.48 Billion | 850.97 Million | 223.27 Million | -902.78 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 120.8 Million | 677.2 Million | 212.6 Million | 57 Million | 135.7 Million | 76.1 Million |
| Depreciation & Amortization | - | 1.74 Billion | - | 441.6 Million | 842.2 Million | 410.1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 78.5 Million | - | - | - | - |
| Change in working capital | - | -271.8 Million | - | - | -614.6 Million | - |
| Other non-cash items | -120.8 Million | 854.9 Million | -212.6 Million | -57 Million | -135.7 Million | -76.1 Million |
| Investing Cash Flow | - | -2.25 Billion | - | - | -633.6 Million | - |
| Investments in PPE | - | -1.85 Billion | - | - | -636.9 Million | - |
| Acquisitions | - | -450 Million | - | - | - | - |
| Investment purchases | - | -265.7 Million | - | - | - | - |
| Sales/Maturities of investments | - | 900 Thousand | - | - | - | - |
| Other Investing Activities | - | -50.5 Million | - | - | 3.3 Million | - |
| Financing Cash Flow | - | -640.2 Million | - | - | -573.7 Million | - |
| Debt repayment | - | -1.38 Billion | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 19.5 Million | - | - | - | - |
| Other Financing Activities | - | -422 Million | - | - | -573.7 Million | - |
| Accounts receivables | - | -278.2 Million | - | - | -581 Million | - |
| Accounts payables | - | 99.5 Million | - | - | - | - |
| Inventory | - | -39.5 Million | - | - | -33.6 Million | - |
| Other working capital | - | -53.6 Million | - | - | - | - |
| Cash at beginning of period | - | 1.71 Billion | - | 1.18 Billion | 39.3 Million | 1.74 Billion |
| Cash at end of period | - | 1.66 Billion | - | 2.06 Billion | 1.14 Billion | 2.56 Billion |
| Capital Expenditure | - | -1.85 Billion | - | - | -636.9 Million | - |
| Effect of forex changes on cash | - | - | - | - | 1.71 Billion | - |
| Net cash flow / Change in cash | - | -51.7 Million | - | 883.2 Million | 1.1 Billion | 820.2 Million |
| Free Cash Flow | - | 989 Million | - | 883.2 Million | - | 820.2 Million |
BBY
000609
002330
BNIGF
RH
BMO